HeyJaredMegan Garlapow
- Indexed articles, last 90 days
- 85
- Latest publication
- Sep 30, 2026
- Outlet visibility, for Endocrinology Advisor
- Top 5M sites
- Earliest in this view
- Jul 6, 2026
Latest articles
Lactoferrin Boosts Oral Iron Response in Anemia of CKD and Dialysis (opens the original)
Read excerpt
Adding lactoferrin to oral iron therapy increases hemoglobin and iron measures more than oral iron alone among patients with iron-deficiency anemia and chronic kidney disease (CKD), including those receiving dialysis, according to trial results. Adding lactoferrin further reduced erythrocyte sedimentation rate (ESR) and hepcidin in several analyses, whereas its effects on other inflammatory markers were less consistent. Lactoferrin is naturally found in milk and various mucosal secretions. It en
CAR T-Cell Therapy Shows Early Efficacy but Limited Durability in PCNSL - Oncology Nurse Advisor (opens the original)
Read excerpt
Chimeric antigen receptor T-cell (CAR-T) therapy can produce substantial initial disease control in primary central nervous system lymphoma (PCNSL), but the benefit appears less durable with longer follow-up, according to a systematic review and meta-analysis published in Immunotherapy. Across 15 studies involving 194 patients, the pooled overall response rate was 68% (95% CI, 59-76; I2 =17%), including a complete response rate of 57% (95% CI, 49-65; I2 =4%). Pooled progression-free survival (PF
Psilocybin Prevents Chemotherapy-Induced Neuropathy by Preserving Axonal Energy - Oncology Nurse Advisor (opens the original)
Read excerpt
Prophylactic psilocybin prevented chemotherapy-induced peripheral neuropathy (CIPN) in multiple mouse models by preserving mitochondrial transport within peripheral sensory axons, according to a study published in Science. The protection persisted through 6 consecutive chemotherapy cycles and up to 8 months of follow-up and did not diminish antitumor activity. The findings identify serotonin 2A (5-HT2A) signaling and axonal energy distribution as potential targets for CIPN prevention, although t
Managing the Challenges of Nontraditional Chemotherapy Routes and Settings (opens the original)
Read excerpt
Chemotherapy administration increasingly extends beyond traditional oncology units, creating safety challenges when specialized treatments are delivered through less familiar routes or by nurses who do not routinely administer antineoplastic agents. Standardized policies, competency validation, appropriate protective measures, and close collaboration with oncology specialists can help reduce risks across care settings, explained Tiffany Kurtz, MSN, RN, OCN, NE-BC, RN manager of Outpatient Oncolo
Managing the Challenges of Nontraditional Chemotherapy Routes and Settings - Oncology Nurse Advisor (opens the original)
Read excerpt
Chemotherapy administration increasingly extends beyond traditional oncology units, creating safety challenges when specialized treatments are delivered through less familiar routes or by nurses who do not routinely administer antineoplastic agents. Standardized policies, competency validation, appropriate protective measures, and close collaboration with oncology specialists can help reduce risks across care settings, explained Tiffany Kurtz, MSN, RN, OCN, NE-BC, RN manager of Outpatient Oncolo
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5M sites
For Endocrinology Advisor, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.